Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today provided ...

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT FDA Response to 510 (k) Filing On October 6, 2024, Monogram (NASDAQ:MGRM) announced it had received an Additional Information ...

Monogram has obtained FDA clearance for mPress implants and applied for 510 (k) clearance for its robotic products. The Company is required to obtain FDA clearance before it can market its products.

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT FDA Response to 510(k) Filing On October 6, 2024, Monogram (NASDAQ:MGRM) announced it had received an Additional Information ...